These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2456 related articles for article (PubMed ID: 27662799)

  • 21. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
    Varney SJ; Guest JF
    Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing unintended pregnancy among young women in Kenya: prospective cohort study to offer contraceptive implants.
    Hubacher D; Olawo A; Manduku C; Kiarie J; Chen PL
    Contraception; 2012 Nov; 86(5):511-7. PubMed ID: 22633247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia.
    Brunie A; Stankevitz K; Nwala AA; Nqumayo M; Chen M; Danna K; Afolabi K; Rademacher KH
    Lancet Glob Health; 2021 Oct; 9(10):e1431-e1441. PubMed ID: 34474001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-year continuation of reversible contraception.
    Diedrich JT; Zhao Q; Madden T; Secura GM; Peipert JF
    Am J Obstet Gynecol; 2015 Nov; 213(5):662.e1-8. PubMed ID: 26259905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya.
    Hubacher D; Masaba R; Manduku CK; Chen M; Veena V
    Contraception; 2015 Apr; 91(4):295-300. PubMed ID: 25601351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection, Initiation, Continuation, and Efficacy of Reversible Contraception Among Enlisted U.S. Service Women in Their First Term of Service From 2012 to 2020.
    Roberts CM; Smalley JM; Adelman WP; Weir LF; Hisle-Gorman E
    Mil Med; 2024 Jan; 189(1-2):e227-e234. PubMed ID: 37542725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
    Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
    Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postpartum contraception.
    Sober S; Schreiber CA
    Clin Obstet Gynecol; 2014 Dec; 57(4):763-76. PubMed ID: 25264698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
    Rose SB; Garrett SM; Stanley J
    Contraception; 2015 Jul; 92(1):17-25. PubMed ID: 25818594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plan A: postabortion contraception.
    Micks E; Prager S
    Clin Obstet Gynecol; 2014 Dec; 57(4):751-62. PubMed ID: 25254920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review.
    Birgisson NE; Zhao Q; Secura GM; Madden T; Peipert JF
    J Womens Health (Larchmt); 2015 May; 24(5):349-53. PubMed ID: 25825986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa.
    Beesham I; Bosman S; Beksinska M; Scoville CW; Smit J; Nanda K
    Contraception; 2022 Apr; 108():37-43. PubMed ID: 34848180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the uptake of long acting reversible contraception: a review.
    Michie L; Cameron ST
    Minerva Ginecol; 2013 Jun; 65(3):241-52. PubMed ID: 23689167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current evidence of contraceptive uptake, pregnancy and continuation rates in young women: a systematic review and Meta-analysis.
    Farah D; Andrade TRM; Di Bella ZIKJ; Girão MJBC; Fonseca MCM
    Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):492-501. PubMed ID: 33140990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg versus other long-acting reversible contraceptives for contraception in Spain.
    Conde JCQ; Parra Ribes I; Perelló-Capo J; Lobo Abascal P; García IC; Andeyro García M; Gutiérrez Alés J; Herrero Conde M; Rius Tarruella J; Espinós Lafuente B
    Eur J Contracept Reprod Health Care; 2024 Oct; 29(5):224-232. PubMed ID: 38989683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of Kenyan women in a prospective cohort study who continue using subdermal contraceptive implants at 12 months.
    O'Neill E; Tang J; Garrett J; Hubacher D
    Contraception; 2014 Mar; 89(3):204-8. PubMed ID: 24360643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database.
    Agostini A; Godard C; Laurendeau C; Benmahmoud Zoubir A; Lafuma A; Lévy-Bachelot L; Gourmelen J; Linet T
    Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):421-426. PubMed ID: 30499732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design.
    Madden T; Paul R; Maddipati R; Buckel C; Goodman M; Peipert JF
    Contraception; 2019 Sep; 100(3):196-201. PubMed ID: 31132346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contraceptive discontinuation and pregnancy postabortion in Nepal: a longitudinal cohort study.
    Puri M; Henderson JT; Harper CC; Blum M; Joshi D; Rocca CH
    Contraception; 2015 Apr; 91(4):301-7. PubMed ID: 25553872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 123.